Programmed Death 1 Receptor Changes Ex Vivo in HIV-Infected Adults following Initiation of Highly Active Antiretroviral Therapy

• Published in: Clinical and Vaccine Immunology 2012-05, Vol.19 (5), p.752-756
• Main Authors: Spitsin, Sergei, Tustin, Nancy B, Riedel, Eric, Tustin, 3rd, Richard, Murray, Jennifer B, Peck, Lauren M, Khan, Mohammad, Quinn, Joseph, Douglas, Steven D
• Format: Article
• Language: English
• Subjects: Adult; Anti-Retroviral Agents - administration & dosage; Antigens, Fungal - immunology; Antiretroviral Therapy, Highly Active; Candida; Candida - immunology; CD4 antigen; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes - immunology; CD8 antigen; CD8-Positive T-Lymphocytes - immunology; Cell culture; Cell Proliferation; Clinical Immunology; Female; gamma -Interferon; highly active antiretroviral therapy; HIV Infections - drug therapy; HIV Infections - immunology; Human immunodeficiency virus; Human immunodeficiency virus 2; Humans; Infection; Inflammation; Interleukin 10; Interleukin 2; Interleukin 4; Interleukin 5; Lymphocytes; Lymphocytes T; Male; Middle Aged; PD-1 protein; Peripheral blood mononuclear cells; phytohemagglutinins; Programmed Cell Death 1 Receptor - biosynthesis; Receptor mechanisms; Tumor necrosis factor; Viral Load
• ISSN: 1556-6811; 1556-679X; 1556-679X
• DOI: 10.1128/CVI.00093-12

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • [e-mail] Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI